Dermalogica has appointed Cirsten Hannken as the new General Manager for the UK and Ireland, replacing Mark Hermann, who has led the company for the past five years and will depart this month.
Having served as the General Manager of Dermalogica Germany for the last seven years, Hannken brings extensive familiarity with the brand to her new position.
Hermann is resigning from his position to explore new adventures with his family, as stated in a press release by the Unilever-owned brand. Hannken expressed her enthusiasm about continuing her journey with Dermalogica in the UK market and joining a capable team. She emphasized her excitement about immersing herself in the professional industry of the UK, especially after leading the successful launch of Dermalogica’s Pro Pen and expansion into advanced services in her previous role. Hannken also hinted at the forthcoming innovations and technologies, suggesting that the brand’s future holds even greater potential.
In 2023, after the appointment of the new CEO Hein Schumacher, Unilever underwent a series of reforms, including the divestment of non-core properties and a focus on 30 brands with greater potential. Additionally, they sought to divest their ice cream business.
In the first quarter of 2024, Unilever’s revenue reached 15 billion euros, marking a 1.4% year-on-year increase. Strong growth was observed in the beauty, health, and personal care segments.
The Beauty & Wellbeing segment recorded a sales figure of 3.2 billion euros in the first quarter, reflecting a 3.1% year-on-year growth. Notably, hair care achieved mid-single-digit growth, driven by significant increases in Clear, TRESemmé, and double-digit growth in Sunsilk. Moreover, core skincare witnessed mid-single-digit growth in India and the United States. With the successful introduction of Gluta Hya body care products in new markets and the launch of new products, sales of Vaseline also saw double-digit growth.
In the Personal Care segment, first-quarter revenue amounted to 3.4 billion euros, with a 0.4% year-on-year growth. Antiperspirants experienced double-digit growth, fueled by strong performances in Latin America and Europe. Brands like Sure and Axe sustained positive growth momentum, leveraging their longstanding platforms, 72-hour sweat and odor protection, and premium fragrance collections.
